Biogenes Technologies Sdn Bhd (Biogenes), a Malaysian biotech startup, has bagged US$5.7 million for its Series A funding from Pembangunan Ekuiti Sdn Bhd (PESB), according to a January 18 press release.
KUALA LUMPUR, Jan 24 (Bernama) — Sensor technology provider, Biogenes Technologies Sdn Bhd, aims to increase the commercialisation of test kit technology using aptamers built by the company, APTSENS, in the Asian region within the next five to 10 years, founder and chief commercial officer Adrian Joseph said.
KUALA LUMPUR, 24 Jan (Bernama) — Penyedia teknologi penderia Biogenes Technologies Sdn Bhd menyasarkan untuk mempertingkat pengkomersialan teknologi kit ujian menggunakan aptamer yang dibangunkannya, APTSENSE di rantau Asia dalam tempoh 5-10 tahun akan datang.
Biogenes Technologies Sdn Bhd (Biogenes), a Malaysian Research and Development (R&D) startup commercializing healthcare diagnostics using aptamers (synthetic antibodies), recently announced securing $5.7m during a Series A funding round from Pembangunan Ekuiti Sdn Bhd (PESB), a Malaysian Venture Capital Management Corporation registered with Securities Commission Malaysia.
KUALA LUMPUR: TT Vision Holdings Bhd’s (TTVHB) debut on the ACE Market yesterday saw its shares opening at RM1.49, which represented a 338.24% premium over its issue price of 34 sen per share.
KUALA LUMPUR: Biogenes Technologies Sdn Bhd (Biogenes) is gearing up to hit its next milestone after receiving RM5.5 million in funding.
Biogenes Technologies Sdn Bhd (Biogenes), a Malaysian biotech startup, has bagged US$5.7 million for its Series A funding from Pembangunan Ekuiti Sdn Bhd (PESB), according to a January 18 press release.
PETALING JAYA: TT Vision Holdings Bhd (TTVHB) made an eye-catching debut on the ACE Market of Bursa Malaysia Securities today, opening at RM1.49 for a 338.24% premium over its issue price of 34 sen per share on volume of 7.05 million shares.
KUALA LUMPUR (Jan 18): TT Vision Holdings Bhd made an impressive debut on the ACE Market of Bursa Malaysia on Wednesday (Jan 18).
Biogenes Technologies develops, produces, and markets synthetic antibody diagnostics products via its proprietary platform. The biotech firm is headquartered in Malaysia and plans to enter Indonesia and the Philippines this year.
Address : Ground Floor, Menara Yayasan Tun Razak, Jalan Bukit Bintang, 55100 Kuala Lumpur, Malaysia
Telephone : +603-2172 6000
Fax : +603-2163 7541
Email : comms@mtdc.com.my
Location : Google Maps
